Schrodinger Inc
Research Schrodinger Inc (SDGR) on Bullrun: market cap USD 1.49B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSDGR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Market capUSD 1.49B
- Financial periodQ2 2026
- RevenueUSD 58.89M
- Net incomeUSD 5.98M
- Free cash flow-USD 34.43M
- Gross margin55.1%
Valuation Snapshot
latest market cap is USD 1.49B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 255.87M | -USD 103.27M | USD 12.46M | 55.7% | -1.41 | USD 230.52M | USD 109.23M | USD 364.05M |
| FY2024 | USD 207.54M | -USD 187.12M | -USD 164.68M | 63.6% | -2.57 | USD 147.33M | USD 117.83M | USD 421.45M |
| FY2023 | USD 216.67M | USD 40.72M | -USD 150.14M | 64.9% | 0.54 | USD 155.32M | USD 127.88M | USD 548.56M |
| FY2022 | USD 180.96M | -USD 149.19M | -USD 127.70M | 55.8% | -2.1 | USD 90.47M | USD 95.29M | USD 447.89M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.49B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.32B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 1.41B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.58B | 63.9 | n/a | n/a |
| 2022 | 2022-12-30 | USD 1.33B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 2.47B | n/a | n/a | n/a |
About Schrodinger Inc
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Schrodinger Inc's market cap?
Schrodinger Inc's market capitalization is USD 1.49B.
What does Schrodinger Inc do?
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries.